skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index
Refined by: xxx: xxx remove Database: Taylor & Francis Open Access remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Effect of Urinary Albumin Creatinine Ratio on Cardiovascular Morbidity and Mortality in Diabetes Patients with Atherosclerotic Disease
Effect of Urinary Albumin Creatinine Ratio on Cardiovascular Morbidity and Mortality in Diabetes Patients with Atherosclerotic Disease
Material Type:
Article 		Add to My Research

Effect of Urinary Albumin Creatinine Ratio on Cardiovascular Morbidity and Mortality in Diabetes Patients with Atherosclerotic Disease

Diabetes, metabolic syndrome and obesity, 2023-01, Vol.16, p.819-828 [Peer Reviewed Journal]

2023 Gao et al. ;COPYRIGHT 2023 Dove Medical Press Limited ;2023 Gao et al. 2023 Gao et al. ;ISSN: 1178-7007 ;EISSN: 1178-7007 ;DOI: 10.2147/DMSO.S400970 ;PMID: 36959900

Full text available

Citations Cited by
2
How well can familial hypercholesterolemia be identified in an electronic health record database?
How well can familial hypercholesterolemia be identified in an electronic health record database?
Material Type:
Article 		Add to My Research

How well can familial hypercholesterolemia be identified in an electronic health record database?

Clinical epidemiology, 2018-01, Vol.10, p.1667-1677 [Peer Reviewed Journal]

COPYRIGHT 2018 Dove Medical Press Limited ;COPYRIGHT 2018 Dove Medical Press Limited ;2018. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2018 Mues et al. This work is published and licensed by Dove Medical Press Limited 2018 ;ISSN: 1179-1349 ;EISSN: 1179-1349 ;DOI: 10.2147/CLEP.S176853 ;PMID: 30532597

Full text available

Citations Cited by
3
Lipid Testing Trends in the US Before and After the Release of the 2013 Cholesterol Treatment Guidelines
Lipid Testing Trends in the US Before and After the Release of the 2013 Cholesterol Treatment Guidelines
Material Type:
Article 		Add to My Research

Lipid Testing Trends in the US Before and After the Release of the 2013 Cholesterol Treatment Guidelines

Clinical epidemiology, 2020-01, Vol.12, p.835-845 [Peer Reviewed Journal]

2020 Levintow et al. ;COPYRIGHT 2020 Dove Medical Press Limited ;COPYRIGHT 2020 Dove Medical Press Limited ;2020. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 Levintow et al. 2020 Levintow et al. ;ISSN: 1179-1349 ;EISSN: 1179-1349 ;DOI: 10.2147/CLEP.S259757 ;PMID: 32801921

Full text available

Citations Cited by
4
Improving glycemic and cholesterol control through an integrated approach incorporating colesevelam - a clinical perspective
Improving glycemic and cholesterol control through an integrated approach incorporating colesevelam - a clinical perspective
Material Type:
Article 		Add to My Research

Improving glycemic and cholesterol control through an integrated approach incorporating colesevelam - a clinical perspective

Diabetes, metabolic syndrome and obesity, 2009-01, Vol.2, p.11-21 [Peer Reviewed Journal]

2009. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1178-7007 ;EISSN: 1178-7007 ;DOI: 10.2147/DMSO.S3866

Full text available

Citations Cited by
5
Targeting gut microbiota in aging-related cardiovascular dysfunction: focus on the mechanisms
Targeting gut microbiota in aging-related cardiovascular dysfunction: focus on the mechanisms
Material Type:
Article 		Add to My Research

Targeting gut microbiota in aging-related cardiovascular dysfunction: focus on the mechanisms

Gut microbes, 2023-12, Vol.15 (2), p.2290331-2290331 [Peer Reviewed Journal]

2023 The Author(s). Published with license by Taylor & Francis Group, LLC. 2023 ;2023 The Author(s). Published with license by Taylor & Francis Group, LLC. 2023 The Author(s) ;ISSN: 1949-0976 ;EISSN: 1949-0984 ;DOI: 10.1080/19490976.2023.2290331 ;PMID: 38073096

Full text available

Citations Cited by
6
Patient participation in decision-making about cardiovascular preventive drugs - resistance as agency
Patient participation in decision-making about cardiovascular preventive drugs - resistance as agency
Material Type:
Article 		Add to My Research

Patient participation in decision-making about cardiovascular preventive drugs - resistance as agency

Scandinavian journal of primary health care, 2017-09, Vol.35 (3), p.231-239 [Peer Reviewed Journal]

2017 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2017 ;2017 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. This work is licensed under the Creative Commons Attribution – Non-Commercial License http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;info:eu-repo/semantics/openAccess ;ISSN: 0281-3432 ;ISSN: 1502-7724 ;EISSN: 1502-7724 ;DOI: 10.1080/02813432.2017.1288814 ;PMID: 28277056

Full text available

Citations Cited by
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait